Your browser doesn't support javascript.
loading
BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential.
Severson, Tesa M; Peeters, Justine; Majewski, Ian; Michaut, Magali; Bosma, Astrid; Schouten, Philip C; Chin, Suet-Feung; Pereira, Bernard; Goldgraben, Mae A; Bismeijer, Tycho; Kluin, Roelof J C; Muris, Jettie J F; Jirström, Karin; Kerkhoven, Ron M; Wessels, Lodewyk; Caldas, Carlos; Bernards, René; Simon, Iris M; Linn, Sabine.
Afiliação
  • Severson TM; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Peeters J; Agendia NV, Amsterdam, The Netherlands.
  • Majewski I; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Michaut M; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bosma A; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Schouten PC; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Chin SF; CRUK Cambridge Institute, Cambridge, UK.
  • Pereira B; CRUK Cambridge Institute, Cambridge, UK.
  • Goldgraben MA; CRUK Cambridge Institute, Cambridge, UK.
  • Bismeijer T; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Kluin RJ; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Muris JJ; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Jirström K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden.
  • Kerkhoven RM; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Wessels L; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Caldas C; CRUK Cambridge Institute, Cambridge, UK.
  • Bernards R; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Simon IM; Agendia NV, Amsterdam, The Netherlands.
  • Linn S; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, The Netherlands. Electronic address: s.linn@nki.nl.
Mol Oncol ; 9(8): 1528-38, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26004083
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Genes BRCA1 / Terapia de Alvo Molecular / Transcriptoma / Neoplasias de Mama Triplo Negativas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Mol Oncol Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Genes BRCA1 / Terapia de Alvo Molecular / Transcriptoma / Neoplasias de Mama Triplo Negativas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Mol Oncol Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos